Survey on Liposomes from Nanomedicines WG

Submitted by c.angulo on Fri, 08/07/2020 - 13:37
The NWG is conducting a Survey on Regulatory Requirements and Research Needs for Liposome Products amongst stakeholders, including Regulatory Agencies

Updated IDMP FAQ

Submitted by c.angulo on Wed, 07/22/2020 - 18:49
The Working Group on Identification of Medicinal Products (IDMP) has updated its Frequently Asked Questions (FAQ) document to address questions relate

IPRP - 5th Meeting - Public Statement

Submitted by c.angulo on Thu, 06/11/2020 - 11:00
The Management Committee (MC) of the International Pharmaceutical Regulators Programme (IPRP) held its fifth meeting on the 28th of May 2020. Represen

IPRP - 4th Meeting - Public Statement

Submitted by c.angulo on Wed, 12/04/2019 - 14:51
The fourth meeting of the International Pharmaceutical Regulators Programme (IPRP) Management Committee (MC) was held on the 20th and 21st of November

Outcome of WHO survey on reliance

Submitted by c.angulo on Fri, 06/21/2019 - 13:56
A focus topic of the IPRP MC meeting in Amsterdam, the Netherlands, on 2-3 June 2019, was reliance, the act by which one regulatory authority takes in

IDMP FAQ

Submitted by c.angulo on Tue, 06/18/2019 - 09:40
The Working Group on Identification of Medicinal Products (IDMP) has published a Frequently Asked Questions (FAQ) document to address questions relate
Subscribe to